Skip to content
National Cancer Institute
at the National Institutes of Health
Send to Printer
Chronic Myelogenous Leukemia Treatment (PDQ®)
Patient Version
Last Modified:
03/25/2013
Relapsed Chronic Myelogenous Leukemia
In
relapsed
CML
, the number of
blast cells
increases after a
remission
.